IL-22 as a prognostic and diagnostic marker in rheumatoid arthritis
Bone erosion prognosis in rheumatoid arthritis. Interleukin-22 (IL-22) has been identified as a prognostic marker for bone erosion associated with rheumatoid arthritis and as a diagnostic marker for the progression of the disease. Generally, the concentration of IL-22 can be determined
by detecting the IL-22 protein but also by detecting the amount of IL-22 mRNA transcripts (e.g. by detecting hybridization to a gene transcript of the IL-22 gene or by PCR methods, such as Real-time PCR), for instance in the tissue.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
State-wide center for quantum science
Karlsruhe Institute of Technology joins IQST as a new partner. The mission of IQST is to further our understanding of nature and develop innovative technologies based on quantum science by…
Newly designed nanomaterial shows promise as antimicrobial agent
Rice scientists develop nanocrystals that kill bacteria under visible light. Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective and easy to produce. After…
Paving the way for diagnostics
Chemists at the University of Jena develop graphene-based biosensor. Just like other biosensors, a graphene-based biosensor requires a functionalised surface on which only specific molecules can attach. If, for example,…